Search research articles
Contact Us
Filters
Showing results (141-150 of 163) with videos related to
Page
of 17
Sort By:
Frontiers in Oncology
|
December 6, 2021
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300
Giulia Marvaso, Barbara Vischioni, Matteo Pepa, et al.
BJR Open
|
March 25, 2024
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial
Marco Lorenzo Bonù, Alessandro Magli, Davide Tomasini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 16, 2020
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
Barbara Alicja Jereczek-Fossa, Matteo Pepa, Giulia Marvaso, et al.
BMC Medical Imaging
|
February 11, 2023
Comparison of automated segmentation techniques for magnetic resonance images of the prostate
Lars Johannes Isaksson, Matteo Pepa, Paul Summers, et al.
European Urology Focus
|
April 2, 2025
Metastasis-directed Therapy in the Management of Urothelial Carcinoma: A Systematic Review and Meta-analysis
Marcin Miszczyk, Mateusz Bilski, Tamás Kói, et al.
The Lancet. Oncology
|
March 6, 2025
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial
Giulia Marvaso, Giulia Corrao, Mattia Zaffaroni, et al.
Cancers
|
July 2, 2021
Exploring miRNA Signature and Other Potential Biomarkers for Oligometastatic Prostate Cancer Characterization: The Biological Challenge behind Clinical Practice. A Narrative Review
Giulia Corrao, Mattia Zaffaroni, Luca Bergamaschi, et al.
European Radiology
|
August 28, 2020
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218)
Simone Giovanni Gugliandolo, Matteo Pepa, Lars Johannes Isaksson, et al.
Oral Diseases
|
April 22, 2020
Prognostic significance of neutrophil-to-lymphocyte ratio in HPV status era for oropharyngeal cancer
Giuseppe Fanetti, Daniela Alterio, Giulia Marvaso, et al.
European Radiology
|
March 20, 2024
Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models
Giulia Marvaso, Lars Johannes Isaksson, Mattia Zaffaroni, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 163) with videos related to
Sort By:
Page
of 17
Frontiers in Oncology
|
December 6, 2021
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300
Giulia Marvaso, Barbara Vischioni, Matteo Pepa, et al.
BJR Open
|
March 25, 2024
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial
Marco Lorenzo Bonù, Alessandro Magli, Davide Tomasini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 16, 2020
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
Barbara Alicja Jereczek-Fossa, Matteo Pepa, Giulia Marvaso, et al.
BMC Medical Imaging
|
February 11, 2023
Comparison of automated segmentation techniques for magnetic resonance images of the prostate
Lars Johannes Isaksson, Matteo Pepa, Paul Summers, et al.
European Urology Focus
|
April 2, 2025
Metastasis-directed Therapy in the Management of Urothelial Carcinoma: A Systematic Review and Meta-analysis
Marcin Miszczyk, Mateusz Bilski, Tamás Kói, et al.
The Lancet. Oncology
|
March 6, 2025
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial
Giulia Marvaso, Giulia Corrao, Mattia Zaffaroni, et al.
Cancers
|
July 2, 2021
Exploring miRNA Signature and Other Potential Biomarkers for Oligometastatic Prostate Cancer Characterization: The Biological Challenge behind Clinical Practice. A Narrative Review
Giulia Corrao, Mattia Zaffaroni, Luca Bergamaschi, et al.
European Radiology
|
August 28, 2020
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218)
Simone Giovanni Gugliandolo, Matteo Pepa, Lars Johannes Isaksson, et al.
Oral Diseases
|
April 22, 2020
Prognostic significance of neutrophil-to-lymphocyte ratio in HPV status era for oropharyngeal cancer
Giuseppe Fanetti, Daniela Alterio, Giulia Marvaso, et al.
European Radiology
|
March 20, 2024
Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models
Giulia Marvaso, Lars Johannes Isaksson, Mattia Zaffaroni, et al.
Page
of 17